RecruitingNCT01503190
The Immune System's Response to Young Women's Breast Cancer
A Translational Study of the Interactions Between Prior Pregnancy and the Biologic Subtype of Breast Cancer in Defining the Cancer: Host Immunologic Interaction
Sponsor
University of Colorado, Denver
Enrollment
800 participants
Start Date
Jul 21, 2009
Study Type
OBSERVATIONAL
Conditions
Summary
This study plans to learn more about the immune system's response to breast cancer in young women.
Eligibility
Sex: FEMALEMin Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study is investigating how the immune system responds to breast cancer in younger women, by analyzing tumor tissue and blood samples to look for patterns that could predict treatment outcomes and guide better therapies.
**You may be eligible if...**
- You are a woman over 18 years old
- You have been diagnosed with breast cancer (confirmed by lab testing)
- Tumor tissue samples are available or will be available from your biopsy or surgery
- You are willing to have fresh tissue collected during your procedure
**You may NOT be eligible if...**
- You are unwilling to have tissue samples collected
- You are unable to provide informed consent
- Tumor tissue is not available and cannot be collected
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(5)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01503190
Related Trials
Genomic Services Research Program
NCT025959571 location
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
NCT052833304 locations
A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)
NCT070671381 location
Social and Environmental Determinants of Breast Cancer Survivorship: the Black Breast Cancer Survivor's Intervention (BBCSI)
NCT068852031 location
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
NCT06103864316 locations